Regulator mandates full review of globally unapproved drugs
India's drug regulator has clarified that new drugs not yet approved anywhere in the world must undergo the full domestic regulatory process, even if Indian patients participated in global clinical trials. The…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.